<div id="readability-page-1"><div>Johnson &amp; Johnson to Host Investor Conference Call on Fourth-Quarter Results Johnson &amp; Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, January 21st to review fourth-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson &amp; Johnson’s executive team. Investors and other interested parties can access the webcast/conference call in the following ways: <ul> <li> The webcast and presentation material are accessible at Johnson &amp; Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes. </li> <li> By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261. </li> <li> A replay of the conference call will be available until approximately 12:00 a.m. on February 4th. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13757287. </li> <li> The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call. </li> <li> Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the first-quarter date of Tuesday, April 14th, 2026. </li> </ul> About Johnson &amp; Johnson At Johnson &amp; Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTEyMTUwNzk2MDFyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTEyMTUwNzk2MDFyMQ"/> Media contact: media-relations@its.jnj.com Investor contact: investor-relations@its.jnj.com View source version on businesswire.com: https://www.businesswire.com/news/home/20251215079601/en/</div></div>

强生

强生将在 1 月 21 日上午 8:30（东部时间）召开投资者电话会议，讨论第四季度业绩。此次会议将由首席执行官霍金·杜阿托、首席财务官约瑟夫·J·沃尔克和投资者关系副总裁达伦·斯内尔格罗夫主持。网络直播和演示材料将在他们的网站上提供，回放可在 2 月 4 日之前访问。为美国和国际参与者提供了拨入号码

强生公司将举办投资者电话会议，讨论第四季度业绩